Homeopathic Tuberculinum Drug Recalled for Manufacturing Practice Deviations
Washington Homeopathic Products is recalling Tuberculinum homeopathic drug in multiple potencies due to manufacturing practice deviations. The voluntary recall affects product distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall initiated by the manufacturer due to manufacturing practice deviations. No illnesses or injuries have been reported, and the specific nature of the manufacturing deviations is not detailed in the source, making this a precautionary quality-control recall rather than an active safety threat.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Tuberculinum homeopathic drug available in potencies of 1X, 12X, 24X, 30X, and 1M in liquid pellet form. This prescription-only product was distributed nationwide across the United States. The recalled lot numbers are 20388 and 22728.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations discovered during manufacturing operations. The manufacturer voluntarily initiated this recall in response to these deviations.
The recall was terminated on May 25, 2023, indicating that the firm completed corrective actions.
The recalled product
- Product
- Tuberculinum, Potency: 1X, 12X, 24X, 30X, 1M, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 20388
- 22728
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01